Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis

Published:2011-01-20 Issue:7 Volume:41 Page:719-733
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Huang Gang,Xu Jun-bo,Liu Jian-xiong,He Yong,Nie Xiao-li,Li Qiu,Hu Yong-mei,Zhao Si-qin,Wang Mian,Zhang Wen-yong,Liu Xiao-rong,Wu Tao,Arkin Akram,Zhang Ting-jie

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.2010.02460.x/fullpdf

Reference44 articles.

1. Epidemiologic features of chronic atrial fibrillation: the Framingham study;Kannel;N Engl J Med,1982

2. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

3. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study;Stewart;Am J Med,2002

4. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

5. Ionic mechanisms of electrical remodeling in human atrial fibrillation;Bosch;Cardiovasc Res,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of renin angiotensin aldosterone modulators mitigating Atrial Fibrillation risk in hypertensive patients;The American Journal of the Medical Sciences;2024-07

2. Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation;Frontiers in Cardiovascular Medicine;2023-12-12

3. Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review;Cardiovascular Diabetology;2023-05-24

4. Research Progress of RAAS Blockers in the Prevention of Atrial Fibrillation in Hypertensive Patients;Advances in Clinical Medicine;2023

5. Angiotensin‐receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT‐5A pathway;Clinical and Experimental Pharmacology and Physiology;2022-10-07